Then (1961), Moksha: Letters of Huxley & Osmond
The Clinical Model: Huxley and Osmond's Framework vs. Current Practice
Huxley and Osmond's correspondence between 1955 and 1963 developed the clinical framework that would define psychedelic-assisted therapy: careful patient selection, a psychologically prepared set, a physically comfortable and aesthetically considered setting, a trained guide present throughout, music curated for the session, integration conversations afterward. Osmond's work at Weyburn Mental Hospital in Saskatchewan implemented this framework with LSD for alcoholism treatment with approximately 40-50% lasting sobriety rates.
confirmed
The framework Huxley and Osmond developed in their correspondence is the direct ancestor of every current psychedelic therapy protocol. The MAPS MDMA-AT protocol, the Johns Hopkins psilocybin protocol, and the company psilocybin protocol all specify: preparation sessions before drug administration, a carefully curated physical environment, trained therapists present throughout the session, music selected for the experience, integration sessions afterward. The FDA's August 2024 rejection of the MDMA application cited inadequate therapist training and monitoring, precisely the clinical rigor Osmond was arguing for in 1958. The clinical model is not just vindicated; it is now the FDA-mandated standard for psychedelic research, sixty years after Huxley and Osmond developed it by correspondence.
Sources
- Huxley & Osmond, Moksha (1977 collection)
- MAPS MDMA-AT Treatment Manual (2023)
- Industry psilocybin trial protocol (2024)
- FDA complete response letter on the MDMA-assisted therapy application (August 2024)